Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity

  1. Prithvi Raj
  2. Ekta Rai
  3. Ran Song
  4. Shaheen Khan
  5. Benjamin E Wakeland
  6. Kasthuribai Viswanathan
  7. Carlos Arana
  8. Chaoying Liang
  9. Bo Zhang
  10. Igor Dozmorov
  11. Ferdicia Carr-Johnson
  12. Mitja Mitrovic
  13. Graham B Wiley
  14. Jennifer A Kelly
  15. Bernard R Lauwerys
  16. Nancy J Olsen
  17. Chris Cotsapas
  18. Christine K Garcia
  19. Carol A Wise
  20. John B Harley
  21. Swapan K Nath
  22. Judith A James
  23. Chaim O Jacob
  24. Betty P Tsao
  25. Chandrashekhar Pasare
  26. David R Karp
  27. Quan Zhen Li
  28. Patrick M Gaffney
  29. Edward K Wakeland  Is a corresponding author
  1. University of Texas Southwestern Medical Center, United States
  2. Yale School of Medicine, United States
  3. Oklahoma Medical Research Foundation, United States
  4. Université catholique de Louvain, Belgium
  5. Penn State Medical School, United States
  6. Texas Scottish Rite Hospital for Children, United States
  7. Cincinnati Children's Hospital Medical Center, United States
  8. University of Southern California, United States
  9. University of California, Los Angeles, United States

Abstract

Targeted sequencing of sixteen SLE risk loci among 1349 Caucasian cases and controls produced a comprehensive dataset of the variations causing susceptibility to systemic lupus erythematosus (SLE). Two independent disease association signals in the HLA-D region identified two regulatory regions containing 3562 polymorphisms that modified thirty-seven transcription factor binding sites. These extensive functional variations are a new and potent facet of HLA polymorphism. Variations modifying the consensus binding motifs of IRF4 and CTCF in the XL9 regulatory complex modified the transcription of HLA-DRB1, HLA-DQA1 and HLA-DQB1 in a chromosome-specific manner, resulting in a 2.5-fold increase in the surface expression of HLA-DR and DQ molecules on dendritic cells with SLE risk genotypes, which increases to >4-fold after stimulation. Similar analyses of fifteen other SLE risk loci identified 1206 functional variants tightly linked with disease-associated SNPs and demonstrated that common disease alleles contain multiple causal variants modulating multiple immune system genes.

Article and author information

Author details

  1. Prithvi Raj

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Ekta Rai

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Ran Song

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Shaheen Khan

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Benjamin E Wakeland

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Kasthuribai Viswanathan

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Carlos Arana

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Chaoying Liang

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Bo Zhang

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Igor Dozmorov

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Ferdicia Carr-Johnson

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Mitja Mitrovic

    Department of Neurology, Yale School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Graham B Wiley

    Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Jennifer A Kelly

    Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Bernard R Lauwerys

    Pole de pathologies rhumatismales, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Bruxelles, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  16. Nancy J Olsen

    Division of Rheumatology, Department of Medicine, Penn State Medical School, Hershey, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Chris Cotsapas

    Department of Neurology, Yale School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Christine K Garcia

    Eugene McDermott Center for Human Growth and Development, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Carol A Wise

    Sarah M. and Charles E. Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  20. John B Harley

    Cincinnati VA Medical Center, Cincinnati Children's Hospital Medical Center, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  21. Swapan K Nath

    Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
    Competing interests
    The authors declare that no competing interests exist.
  22. Judith A James

    Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
    Competing interests
    The authors declare that no competing interests exist.
  23. Chaim O Jacob

    Department of Medicine, University of Southern California, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  24. Betty P Tsao

    Department of Medicine, University of California, Los Angeles, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  25. Chandrashekhar Pasare

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  26. David R Karp

    Rheumatic Diseases Division, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  27. Quan Zhen Li

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  28. Patrick M Gaffney

    Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
    Competing interests
    The authors declare that no competing interests exist.
  29. Edward K Wakeland

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
    For correspondence
    edward.wakeland@utsouthwestern.edu
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Jonathan Flint, Wellcome Trust Centre for Human Genetics, United Kingdom

Ethics

Human subjects: All the study subjects gave their written informed consent for the study. All the research protocols and methods employed were approved by UT Southwestern Institutional Review Board.

Version history

  1. Received: October 5, 2015
  2. Accepted: February 13, 2016
  3. Accepted Manuscript published: February 15, 2016 (version 1)
  4. Version of Record published: March 17, 2016 (version 2)

Copyright

© 2016, Raj et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,793
    views
  • 1,100
    downloads
  • 97
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Prithvi Raj
  2. Ekta Rai
  3. Ran Song
  4. Shaheen Khan
  5. Benjamin E Wakeland
  6. Kasthuribai Viswanathan
  7. Carlos Arana
  8. Chaoying Liang
  9. Bo Zhang
  10. Igor Dozmorov
  11. Ferdicia Carr-Johnson
  12. Mitja Mitrovic
  13. Graham B Wiley
  14. Jennifer A Kelly
  15. Bernard R Lauwerys
  16. Nancy J Olsen
  17. Chris Cotsapas
  18. Christine K Garcia
  19. Carol A Wise
  20. John B Harley
  21. Swapan K Nath
  22. Judith A James
  23. Chaim O Jacob
  24. Betty P Tsao
  25. Chandrashekhar Pasare
  26. David R Karp
  27. Quan Zhen Li
  28. Patrick M Gaffney
  29. Edward K Wakeland
(2016)
Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity
eLife 5:e12089.
https://doi.org/10.7554/eLife.12089

Share this article

https://doi.org/10.7554/eLife.12089

Further reading

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Weichen Song, Yongyong Shi, Guan ning Lin
    Tools and Resources

    We propose a new framework for human genetic association studies: at each locus, a deep learning model (in this study, Sei) is used to calculate the functional genomic activity score for two haplotypes per individual. This score, defined as the Haplotype Function Score (HFS), replaces the original genotype in association studies. Applying the HFS framework to 14 complex traits in the UK Biobank, we identified 3619 independent HFS–trait associations with a significance of p < 5 × 10−8. Fine-mapping revealed 2699 causal associations, corresponding to a median increase of 63 causal findings per trait compared with single-nucleotide polymorphism (SNP)-based analysis. HFS-based enrichment analysis uncovered 727 pathway–trait associations and 153 tissue–trait associations with strong biological interpretability, including ‘circadian pathway-chronotype’ and ‘arachidonic acid-intelligence’. Lastly, we applied least absolute shrinkage and selection operator (LASSO) regression to integrate HFS prediction score with SNP-based polygenic risk scores, which showed an improvement of 16.1–39.8% in cross-ancestry polygenic prediction. We concluded that HFS is a promising strategy for understanding the genetic basis of human complex traits.

    1. Genetics and Genomics
    2. Immunology and Inflammation
    Jean-David Larouche, Céline M Laumont ... Claude Perreault
    Research Article

    Transposable elements (TEs) are repetitive sequences representing ~45% of the human and mouse genomes and are highly expressed by medullary thymic epithelial cells (mTECs). In this study, we investigated the role of TEs on T-cell development in the thymus. We performed multiomic analyses of TEs in human and mouse thymic cells to elucidate their role in T-cell development. We report that TE expression in the human thymus is high and shows extensive age- and cell lineage-related variations. TE expression correlates with multiple transcription factors in all cell types of the human thymus. Two cell types express particularly broad TE repertoires: mTECs and plasmacytoid dendritic cells (pDCs). In mTECs, transcriptomic data suggest that TEs interact with transcription factors essential for mTEC development and function (e.g., PAX1 and REL), and immunopeptidomic data showed that TEs generate MHC-I-associated peptides implicated in thymocyte education. Notably, AIRE, FEZF2, and CHD4 regulate small yet non-redundant sets of TEs in murine mTECs. Human thymic pDCs homogenously express large numbers of TEs that likely form dsRNA, which can activate innate immune receptors, potentially explaining why thymic pDCs constitutively secrete IFN ɑ/β. This study highlights the diversity of interactions between TEs and the adaptive immune system. TEs are genetic parasites, and the two thymic cell types most affected by TEs (mTEcs and pDCs) are essential to establishing central T-cell tolerance. Therefore, we propose that orchestrating TE expression in thymic cells is critical to prevent autoimmunity in vertebrates.